Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)
China · Delayed Price · Currency is CNY 40.25
-0.82 (-2.00%)
Jun 18, 2026, 3:04 PM CST
SHE:300049 Market Cap
SHE:300049 has a market cap or net worth of 10.63 billion as of June 18, 2026. Its market cap has increased by 33.64% in one year.
Market Cap
10.63B
Enterprise Value
10.46B
Revenue
1.63B
Ranking
n/a
PE Ratio
68.30
Stock Price
40.25
Market Cap Chart
Since January 20, 2010, SHE:300049's market cap has increased from 2.54B to 10.63B, an increase of 318.75%. That is a compound annual growth rate of 9.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 10.63B | -43.05% |
| Dec 31, 2025 | 18.66B | 122.08% |
| Dec 31, 2024 | 8.40B | -26.74% |
| Dec 29, 2023 | 11.47B | 78.43% |
| Dec 30, 2022 | 6.43B | 70.55% |
| Dec 31, 2021 | 3.77B | 80.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jinyu Bio-technology | 12.86B |
| Anhui Anke Biotechnology (Group) | 12.79B |
| Mabwell (Shanghai) Bioscience | 11.95B |
| Tibet Cheezheng Tibetan Medicine | 11.12B |
| HitGen | 11.03B |
| Chengzhi | 10.51B |
| Jiangxi Fushine Pharmaceutical | 10.49B |
| Pacific Shuanglin Bio-pharmacy | 10.27B |